Respirogen Information

Respirogen's technology will provide oxygen independent from damaged lungs. Acute respiratory distress syndrome (ARDS) is an acute severe lung disease commonly encountered in intensive care units (ICU). It can be caused by several triggers, including pneumonia or trauma. It is characterized by widespread injury of the alveolar–capillary membrane, resulting in protein rich noncardiogenic pulmonary edema (fluid accumulation in the lungs) and acute respiratory failure (ARF). ARDS results in severe hypoxaemia, which is refractory to oxygen treatment and requires assisted ventilation.

Website	https://respirogen.com/
Revenue	$5 million
Employees	2 (0 on RocketReach)
Founded	2017
Address	6560 Odell Pl Ste E, Boulder, Colorado 80301, US
Phone	+1 917-648-0228
Technologies	HTML , Twitter , Google Analytics +5 more (view full list)
Industry	Biotechnology Research, Business Services General, Computer, Business Services, Consumer Electronics, Hardware, CRM, Information Technology, Sales and Marketing, Software, Electronics, Robotics, Science and Engineering
Keywords	Lung Disease Treatment, Respiratory Technology, Respiratory Support, Critical Care Medicine, Oxygen Therapy, Intensive Care Unit, Pulmonary Medicine, Advanced Respiratory Care, Life Support Systems, Mechanical Ventilation, Medical Devices, Lung Health, Healthcare Technology, Clinical Trials
Competitors	GE HealthCare, Thermo Fisher Scientific, BD, Agilent Technologies, MilliporeSigma, PerkinElmer, Inc., Waters Corporation, Bio-Rad Laboratories, QIAGEN +44 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies